{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"Participants in this study received JZP-458 as part of a multi-agent chemotherapeutic regimen."},"pointOfContact":{"email":"ClinicalTrialDisclosure@JazzPharma.com","organization":"Jazz Pharmaceuticals","phone":"215-832-3750","title":"Clinical Trial Disclosure & Transparency"}}